Showing 109–120 of 140 results

Tremfya (guselkumab)

£1,900.00
Tremfya (guselkumab) is a medication used for the treatment of adult patients with moderate-to-severe plaque psoriasis and active psoriatic arthritis.

Trikafta* (elexacaftor/tezacaftor/ivacaftor; ivacaftor)

£47,642.65£51,734.09
Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor)* is a medication used for the treatment of cystic fibrosis (CF), indicated for CF patients aged 12 years and older with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that are responsive to Trikafta based on in vitro data.

Truvada (emtricitabine / tenofovir disoproxil)

£750.80
Truvada (emtricitabine / tenofovir disoproxil) is a medication used in combination with at least one other antiviral medicine for the treatment of human immunodeficiency virus type 1 (HIV-1) infection or prevention (PrEP).

Truxima (rituximab)

£1,085.70£2,325.28
Truxima (rituximab) is a medication used for the treatment of follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL); chronic lymphocytic leukemia (CLL); severe active rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis.

Tudcabil (tauroursodeoxycholic acid)

£22.30
Tudcabil (tauroursodeoxycholic acid) is a medication granted orphan designation by the EMA for amyotrophic lateral sclerosis (ALS).

Tymlos (abaloparatide)

£3,220.00
Tymlos (abaloparatide) is a medication used for the treatment of postmenopausal women with osteoporosis at high risk for fracture.

Tyrvaya (varenicline solution)

£1,529.55
Tyrvaya (varenicline solution) is a nasal spray used to treat the signs and symptoms of dry eye disease.

Ultomiris (ravulizumab)

Ultomiris (ravulizumab) is a prescription medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria (PNH) and adults and children with atypical haemolytic uraemic syndrome (aHUS).

Vabysmo (faricimab-svoa)

£1,521.81
Vabysmo (faricimab-svoa) is a prescription medicine that is used to treat two leading causes of vision loss: neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME).

Vascepa (icosapent ethyl)

£400.00
Vascepa (icosapent ethyl) is a prescription medicine used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and as an adjunct to statin therapy to reduce the risk of of cardiovascular events.

Vascepa (icosapent ethyl)

£400.00
Vascepa (icosapent ethyl) is a prescription medicine used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia and as an adjunct to statin therapy to reduce the risk of of cardiovascular events.

Veklury (remdesivir)

£300.00
Veklury (remdesivir) is an antiviral medication indicated for the treatment of COVID-19 in adults and adolescents from 12 years of age with pneumonia who require supplemental oxygen. Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2 infection).